Literature DB >> 27417672

Phosphorylation of cardiac myosin binding protein-C regulates heart contraction and dilatation in vivo during β-adrenergic receptor activation.

Eric R Starr1, Tupa Basuroy2, Xiaoming Fan3, Shengnan Du2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27417672      PMCID： PMC4945709          DOI： 10.1113/JP272680

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  5 in total

Review 1.  β-adrenergic receptor signalling and its functional consequences in the diseased heart.

Authors:  Aref Najafi; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Eur J Clin Invest       Date:  2016-02-19       Impact factor: 4.686

2.  The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Julian E Stelzer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

3.  Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.

Authors:  Ranganath Mamidi; Jiayang Li; Kenneth S Gresham; Julian E Stelzer
Journal:  Pflugers Arch       Date:  2013-12-06       Impact factor: 3.657

4.  The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.

Authors:  Kenneth S Gresham; Julian E Stelzer
Journal:  J Physiol       Date:  2016-02-01       Impact factor: 5.182

Review 5.  Post-translational control of cardiac hemodynamics through myosin binding protein C.

Authors:  Manish K Gupta; Jeffrey Robbins
Journal:  Pflugers Arch       Date:  2013-10-22       Impact factor: 3.657
  5 in total
  1 in total

Review 1.  Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.

Authors:  Marko Ušaj; Luisa Moretto; Alf Månsson
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.